Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00078793
Status:
COMPLETED
Last Update Posted:
2013-05-14
First Post:
2004-03-05
Brief Title:
Registry of Etanercept Enbrel In Children With Juvenile Rheumatoid Arthritis
Sponsor:
Amgen
Organization:
Amgen
Study Overview
Official Title:
Phase IV Registry of Etanercept Enbrel In Children With Juvenile Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2013-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate long-term safety of etanercept with or without other DMARDs in children with polyarticular course or systemic juvenile rheumatoid arthritis JRA compared to a cohort of subjects with polyarticular or systemic JRA receiving methotrexate with or without other DMARDs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 0160026 | None | None | None |